VOPRATELIMAB

UNII:	QXN20J93AH
Formula:
Preferred Substance Name:	VOPRATELIMAB
GSRS Full Record:	QXN20J93AH i

2039148-04-2
ANTI-ICOS AGONIST MAB JTX-2011
ANTI-ICOS AGONIST MONOCLONAL ANTIBODY JTX-2011
IMMUNOGLOBULIN G1, ANTI-(INDUCIBLE T-CELL COSTIMULATOR)(HUMANIZED MONOCLONAL JTX-2011 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED MONOCLONAL JTX-2011 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1-KAPPA, ANTI-( HOMO SAPIENS INDUCIBLE T-CELL COSTIMULATOR (ANTIGEN CD278))HUMANIZED MONOCLONAL ANTIBODY.GAMMA.1 HEAVY CHAIN (1-447) (HUMANIZED VH (HOMO SAPIENS IGHV3-74*01 (89%) (IGHD)-IGHJ5*01) (8.8.10) (1-117)-HOMO SAPIENS IGHG1*03 (CH1(R97>K(214))) (118-447) (220-218')-DISULFIDE WITH KAPPA LIGHT CHAIN (1'-218') (HUMANIZED V-KAPPA (HOMO SAPIENS IGKV4-1*01 (84%) IGKJ3*01) (10.3.9) (1'-111')-HOMO SAPIENS IGKC*01 (112'-218')), DIMER (226-226'':229-229'')-BISDISULFIDE
JTX-2011
VOPRATELIMAB [INN]
VOPRATELIMAB [USAN]
VOPRATELIMAB [WHO-DD]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

VOPRATELIMAB

Synonyms and Mappings

Resources